OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Oncotelic Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026
- Market cap
- $8.66M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Dividends
Oncotelic Therapeutics has not reported a dividend
No dividend per share appears in Oncotelic Therapeutics's annual filings since fiscal 2010.